Award
Delivery Order #SPE2DR26FB9YD
Delivery Order for Quillivant XR Medication Under AmerisourceBergen IDV
Buyer
Defense Logistics Agency
Award Amount
$397.33
Ceiling
$397.33
Awarded
February 26, 2026
Period of Performance
Feb 26, 2026 – Feb 27, 2026
Identifier
SPE2DR26FB9YD
NAICS
424210
This award represents a delivery order contract issued to AmerisourceBergen Drug Corp, a leading pharmaceutical distributor known for supplying vital medications and healthcare products. The contract procures a specific medication, Quillivant XR 25 MG/5 ML Suspension in a 60 ML volume, critical for patient treatment regimens. The significance of this delivery order lies in its role supporting the overarching indefinite delivery vehicle (IDV) with AmerisourceBergen, which ensures consistent pharmaceutical availability to healthcare agencies. The scope of work is narrowly focused on timely delivery of this medication within a brief performance window, furthering the agency’s mission to maintain reliable drug supply chains. This order follows a competitive award process for the parent IDV, promoting fair government procurement practices. The award aligns under the parent contract SPE2DR25D2212 and marks a multi-year strategic partnership in pharmaceutical services. The period of performance for this delivery order is a concise two-day window, reflecting a precise delivery schedule.
Description
4570977742!QUILLIVANT XR 25 MG/5 ML SUSP 60ML